A retrospective cohort study to evaluate the effect of concurrent immunoradiotherapy in patients with metastatic melanoma after progression on nivolumab
Latest Information Update: 09 Jul 2019
At a glance
- Drugs Antineoplastics (Primary) ; Ipilimumab (Primary) ; Nivolumab (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
Most Recent Events
- 09 Jul 2019 New trial record